191 related articles for article (PubMed ID: 25082150)
1. The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses.
Small JC; Haut LH; Bian A; Ertl HC
J Leukoc Biol; 2014 Nov; 96(5):821-31. PubMed ID: 25082150
[TBL] [Abstract][Full Text] [Related]
2. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.
Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HC
J Immunol; 2003 Dec; 171(12):6774-9. PubMed ID: 14662882
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice.
Lin SW; Hensley SE; Tatsis N; Lasaro MO; Ertl HC
J Clin Invest; 2007 Dec; 117(12):3958-70. PubMed ID: 18008010
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
[TBL] [Abstract][Full Text] [Related]
5. Immunodominance of Adenovirus-Derived CD8
Schöne D; Hrycak CP; Windmann S; Lapuente D; Dittmer U; Tenbusch M; Bayer W
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768877
[TBL] [Abstract][Full Text] [Related]
6. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
7. Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.
Lorin C; Vanloubbeeck Y; Baudart S; Ska M; Bayat B; Brauers G; Clarinval G; Donner MN; Marchand M; Koutsoukos M; Mettens P; Cohen J; Voss G
PLoS One; 2015; 10(4):e0122835. PubMed ID: 25856308
[TBL] [Abstract][Full Text] [Related]
8. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses.
Koup RA; Roederer M; Lamoreaux L; Fischer J; Novik L; Nason MC; Larkin BD; Enama ME; Ledgerwood JE; Bailer RT; Mascola JR; Nabel GJ; Graham BS; ;
PLoS One; 2010 Feb; 5(2):e9015. PubMed ID: 20126394
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Immune Response to Adenovirus Serotype 5 Vector by Immunization with Peptides Containing an MHC Class II Epitope and a Thio-Oxidoreductase Motif.
Miao W; Roohi Ahangarani R; Carlier V; Vander Elst L; Saint-Remy JM
Hum Gene Ther; 2016 Mar; 27(3):230-43. PubMed ID: 26711172
[TBL] [Abstract][Full Text] [Related]
10. Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines.
Pillai VK; Kannanganat S; Penaloza-Macmaster P; Chennareddi L; Robinson HL; Blackwell J; Amara RR
Vaccine; 2011 Jul; 29(33):5399-406. PubMed ID: 21651938
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
Barouch DH; Pau MG; Custers JH; Koudstaal W; Kostense S; Havenga MJ; Truitt DM; Sumida SM; Kishko MG; Arthur JC; Korioth-Schmitz B; Newberg MH; Gorgone DA; Lifton MA; Panicali DL; Nabel GJ; Letvin NL; Goudsmit J
J Immunol; 2004 May; 172(10):6290-7. PubMed ID: 15128818
[TBL] [Abstract][Full Text] [Related]
12. Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses.
Provine NM; Badamchi-Zadeh A; Bricault CA; Penaloza-MacMaster P; Larocca RA; Borducchi EN; Seaman MS; Barouch DH
J Virol; 2016 May; 90(9):4278-4288. PubMed ID: 26865713
[TBL] [Abstract][Full Text] [Related]
13. Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.
Pichla-Gollon SL; Lin SW; Hensley SE; Lasaro MO; Herkenhoff-Haut L; Drinker M; Tatsis N; Gao GP; Wilson JM; Ertl HC; Bergelson JM
J Virol; 2009 Jun; 83(11):5567-73. PubMed ID: 19279092
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens.
Tatsis N; Lasaro MO; Lin SW; Haut LH; Xiang ZQ; Zhou D; Dimenna L; Li H; Bian A; Abdulla S; Li Y; Giles-Davis W; Engram J; Ratcliffe SJ; Silvestri G; Ertl HC; Betts MR
J Immunol; 2009 May; 182(10):6587-99. PubMed ID: 19414814
[TBL] [Abstract][Full Text] [Related]
15. High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.
Kron MW; Engler T; Schmidt E; Schirmbeck R; Kochanek S; Kreppel F
J Gene Med; 2011 Dec; 13(12):648-57. PubMed ID: 22095925
[TBL] [Abstract][Full Text] [Related]
16. Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
Bruder JT; Semenova E; Chen P; Limbach K; Patterson NB; Stefaniak ME; Konovalova S; Thomas C; Hamilton M; King CR; Richie TL; Doolan DL
PLoS One; 2012; 7(4):e33920. PubMed ID: 22496772
[TBL] [Abstract][Full Text] [Related]
17. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
18. Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectors.
Thomas MA; Song R; Demberg T; Vargas-Inchaustegui DA; Venzon D; Robert-Guroff M
PLoS One; 2013; 8(10):e76344. PubMed ID: 24143187
[TBL] [Abstract][Full Text] [Related]
19. Use of DAF-displaying adenovirus vectors reduces induction of transgene- and vector-specific adaptive immune responses in mice.
Seregin SS; Aldhamen YA; Appledorn DM; Zehnder J; Voss T; Godbehere S; Amalfitano A
Hum Gene Ther; 2011 Sep; 22(9):1083-94. PubMed ID: 21388344
[TBL] [Abstract][Full Text] [Related]
20. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.
McCoy K; Tatsis N; Korioth-Schmitz B; Lasaro MO; Hensley SE; Lin SW; Li Y; Giles-Davis W; Cun A; Zhou D; Xiang Z; Letvin NL; Ertl HC
J Virol; 2007 Jun; 81(12):6594-604. PubMed ID: 17428852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
